Patents by Inventor Bronwyn Maree Kivell

Bronwyn Maree Kivell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230096920
    Abstract: The present invention relates generally to methods of using nalfurafine for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalfurafine for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalfurafine for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
    Type: Application
    Filed: September 30, 2022
    Publication date: March 30, 2023
    Inventors: Thomas Edward Prisinzano, Bronwyn Maree Kivell, Anne Camille La Flamme
  • Patent number: 11324742
    Abstract: The present invention relates generally to methods of using nalfurafine for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalfurafine for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalfurafine for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: May 10, 2022
    Assignees: Victoria Link Ltd., University of Kansas
    Inventors: Thomas Edward Prisinzano, Bronwyn Maree Kivell, Anne Camille La Flamme
  • Publication number: 20210069179
    Abstract: The present invention relates generally to methods of using nalfurafine for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalfurafine for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalfurafine for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 11, 2021
    Inventors: Thomas Edward Prisinzanno, Bronwyn Maree Kivell, Anne Camille La Flamme
  • Publication number: 20210023074
    Abstract: The present invention relates generally to methods of using nalmefene for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalmefene for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalmefene for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
    Type: Application
    Filed: March 7, 2019
    Publication date: January 28, 2021
    Inventors: Bronwyn Maree Kivell, Anne Camille La Flamme, Thomas Edward Prisinzano
  • Publication number: 20210015813
    Abstract: The present invention relates generally to methods of using nalfurafine for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalfurafine for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalfurafine for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
    Type: Application
    Filed: March 7, 2019
    Publication date: January 21, 2021
    Inventors: Bronwyn Maree Kivell, Anne Camille La Flamme, Thomas Edward Prisinzano